<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Poison Prevention Packaging Requirements; Proposed Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More Than 80 mg of the Drug</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Poison Prevention Packaging Requirements; Proposed Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More Than 80 mg of the Drug</h1>
    <p class="timestamp">Published: 2021-09-16 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Consumer Product Safety Commission (Commission or CPSC) is proposing to amend the child-resistant packaging requirements to exempt baloxavir marboxil tablets in packages containing not more than 80 mg of the drug, currently marketed as XOFLUZA,<SUP>TM</SUP> from the special packaging requirements. XOFLUZA is used to treat the flu, and is taken in one dose within 48 hours of experiencing flu symptoms. The proposed rule would exempt this prescription drug product on the basis that child-resist...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Proposed Rule</p>
    <p><strong>Agency:</strong> Consumer Product Safety Commission</p>
    <p><strong>Document Number:</strong> 2021-19953</p>
    <p><strong>Publication Date:</strong> 2021-09-16</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2021/09/16/2021-19953/poison-prevention-packaging-requirements-proposed-exemption-of-baloxavir-marboxil-tablets-in">https://www.federalregister.gov/documents/2021/09/16/2021-19953/poison-prevention-packaging-requirements-proposed-exemption-of-baloxavir-marboxil-tablets-in</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2021-19953</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
